# Prognostic Biomarkers in Tumor Tissue Samples From Young Patients With Neuroblastoma

> **NCT01358617** · — · COMPLETED · sponsor: **Children's Oncology Group** · enrollment: 90 (actual)

## Conditions studied

- Disseminated Neuroblastoma
- Localized Resectable Neuroblastoma
- Localized Unresectable Neuroblastoma
- Recurrent Neuroblastoma
- Stage 4S Neuroblastoma

## Interventions

- **OTHER:** diagnostic laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT01358617
- **Lead sponsor:** Children's Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2011-08
- **Final completion:** 2011-08
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2015-05-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01358617

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01358617, "Prognostic Biomarkers in Tumor Tissue Samples From Young Patients With Neuroblastoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01358617. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*